„Ægroti Salus Suprema Lex” −

The Benefit of the Patient
is the Highest Law

Since its beginning in early 2019, the ICPO Foundation has already received financial and active personal support from a growing community of internationally acclaimed experts, philanthropists, leading medical and industrial entities, and governmental institutions around the globe.

The ICPO Foundation is honored to be able to celebrate its official inauguration together with the 20th anniversary of Targeted Isotope Therapy in Bad Berka and would in this context like to extend an open invitation to all participants and the emerging international community in Precision Oncology to participate, contribute to, and benefit from its mission to globally expand and continously improve Best Practices and Patient Access in Precison Oncology.


The ICPO Foundation

Board of Trustees

Udo J. Vetter
Michael Lee-Chin
Richard Baum
Oliver Buck

The ICPO Foundation

Executive Management

Martin Bosch
Odile Jaume
Martin Reuter

Join the ICPO

and participate in making a paradigm shift in cancer treatment available to Patients worldwide

ICPO Foundation

News

As part of the 6th Theranostics World Congress June 24 - 26, Wiesbaden, Germany,…

Read more

The International Centers for Precision Oncology (ICPO) Foundation is pleased to…

Read more

The International Centers for Precision Oncology (ICPO) Foundation is pleased to…

Read more

Forward-looking and inspiring message from the ICPO Foundation on how to pave…

Read more

The ICPO Foundation is happy to support the Canadian Urology Association (CUA)…

Read more

ITM and CNL Sign Memorandum of Understanding to Pursue Global Development and…

Read more

We are happy to announce our 2nd ICPO Forum for Theranostics. It will take place…

Read more

This event marked the first of many future collaborations between German and…

Read more

The ICPO Foundation is currently planning to sponsor the Dosimetrie Winter…

Read more

prev

next